Glenmark Gets $40m IFC Loan
Aimed At Boosting Production, Including For COVID-19 Treatments
India’s Glenmark has been granted a $40m loan from the International Finance Corporation, a member of the World Bank Group, to support an increase in production to help improve access to drugs, including COVID-19 treatments.
You may also be interested in...
Action is needed from both the UK government and the European Commission to prevent a collapse of Northern Ireland’s generics market, according to the BGMA.
Canada’s PlantForm has struck a deal with Brazil’s Bio-Manguinhos/Fiocruz to develop a biosimilar pembrolizumab rival to Merck’s Keytruda for the Brazilian market and potentially beyond.
The FTC has won the backing of an appeals court over its 2019 decision that found a reverse-payment settlement deal between Impax and Endo over Opana ER to be anti-competitive and illegal.